AliveCor has been granted FDA clearance for KardiaMobile 6L, the world’s first publicly available six-lead personal electrocardiogram device.

Janesville, Wisconsin-based SHINE Medical Technologies has announced an agreement with the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), gaining exclusive rights over an innovation to produce lutetium-177 (Lu-177).

On February 15 of this year, Congress passed national breast density legislation, which mandates all mammography reports and summaries notify women of their breast density. A trio of researchers discussed whether the law will help or confuse patients in a recent JAMA commentary.

Radiology, the medical specialty into which AI has made the furthest initial inroads in the U.S., is embracing the technology in France. And this is so despite French radiologists feeling underinformed on AI up to now.

The causes of renal cell carcinoma progression may be more complex than outlined in the Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1), according to findings published May 14 in Radiology. One radiologist said the study should be a "wake up call" for the speciality.

Enhanced dual-source dual-energy CT (DECT) can help differentiate invasive adenocarcinomas from preinvasive lesions which appear as pure ground-glass nodules (pGGNs), according to a small study published in the American Journal of Roentgenology.

Researchers have combined a new imaging technique and imaging agent which utilizes a synthesized amino acid found in scorpion venom to help illuminate brain tumors during surgery.

“The results of this research are extremely exciting, as it will significantly impact clinical care,” reported study author Mishal Mendiratta-Lala, MD, with the division of abdominal radiology at Michigan Medicine in Ann Arbor.